COVID-19 IgM/IgG Rapid Test

Manufactured by BioMedomics Inc., United States - www.biomedomics.com 

Related Scientific Literature

• Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
• Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
• Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
• COVID-19 Serological Tests: How Well Do They Actually Perform?
• Genetics of Severe Acute Respiratory Syndrome Coronavirus-2 and Diagnosis of Coronavirus Disease-2019: An Overview
• Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis
• Laboratory diagnosis of SARS-CoV-2 - A review of current methods
• Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review
• Assay Techniques and Test Development for COVID-19 Diagnosis.
• Review of Current Advances in Serologic Testing for COVID-19
• Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
• High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea Massachusetts.

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements